Join the Anesthesia group to help and get support from people like you.
Anesthesia News (Page 2)
Maternal Labor Epidural Analgesia May Be Linked to Autism in Children
WEDNESDAY, July 26, 2023 – Maternal labor epidural analgesia (LEA) was associated with an increased risk for autism spectrum disorder (ASD) among offspring, according to a study published online...
Use of Manometer Can Reduce Endotracheal Tube Cuff Overinflation
MONDAY, July 24, 2023 – Provider education on use of endotracheal tube (ETT) cuff overinflation can reduce overinflation and related complications, according to a study presented at the annual...
Initiating Patient-Controlled Epidural in OR Beneficial for Pain Control
MONDAY, July 24, 2023 – Initiating patient-controlled epidural anesthesia (PCEA) infusion in the operating room (OR) may improve pain control, according to a study presented at the annual American...
Opioid-Related Adverse Event Risk Increased With Modified-Release Opioids
TUESDAY, July 11, 2023 – For patients undergoing total hip or knee arthroplasty, modified-release opioid use in the acute postoperative period is associated with an increased risk for opioid-related...
Anesthesiologists Say Ozempic, Wegovy Should Be Halted Prior to Surgery
MONDAY, July 3, 2023 – The weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia, according to a new warning from the American Society of Anesthesiologists. Semaglutide...
Specific TJA Subgroups Gain Greater Benefit From Peripheral Nerve Blocks
MONDAY, May 15, 2023 – Specific subgroups of patients undergoing total joint arthroplasty (TJA) experience greater benefit from peripheral nerve blocks (PNBs) in terms of reduction in complications,...
FDA Medwatch Alert: Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), Due To The Potential Presence of Visible Particulate
NEW YORK, NY., July 13, 2022 – Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), 100 mL Single Patient Use Glass...
FDA Approves Rezipres (ephedrine hydrochloride injection) for Hypotension During Anesthesia
DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) – Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres (ephedrine...
FDA Approves Byfavo (remimazolam injection) for the Induction and Maintenance of Procedural Sedation
Dublin, Ireland – 2 July 2020: Cosmo Pharmaceuticals announced today that the US Food and Drug Administration (FDA) has approved Byfavo (remimazolam injection) for the induction and maintenance of p...
FDA Approves Emerphed (ephedrine sulfate) Ready-to-Use Injection for Hypotension During Anesthesia
Lincolnshire, Ill., April 21, 2020 — Nexus Pharmaceuticals announced today it has received U.S. Food and Drug Administration (FDA) approval for its patent-pending New Drug Application (NDA) Emerphed, ...
FDA Approves Numbrino (cocaine hydrochloride) Nasal Solution for Nasal Anesthesia
PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA), submitted un...
FDA Medwatch Alert: General Anesthetic and Sedation Drugs: Drug Safety Communication - FDA Approves Label Changes for Use in Young Children
ISSUE: FDA has approved previously announced label changes regarding the use of general anesthetic and sedation medicines in children younger than 3 years. These changes include: A new Warning...
FDA Medwatch Alert: General Anesthetic and Sedation Drugs: Drug Safety Communication - New Warnings for Young Children and Pregnant Women
ISSUE: FDA is warning that repeated or lengthy use of general anesthetic and sedation drugs during surgeries or procedures in children younger than 3 years or in pregnant women during their third...
FDA Medwatch Alert: 0.25 Percent Bupivacaine Hydrochloride Injection, USP by Hospira: Recall - Particulate Matter
ISSUE: Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of 0.25% Bupivacaine Hydrochloride Injection, USP (NDC: 0409-1159-02, Lot 59-064- DK, Expiry 1NOV2017) at the hospital/retail...
FDA Medwatch Alert: PharMEDium Sterile Preparations Compounded With a Single Recalled Lot of Fresenius Kabi Sensorcaine-MPF (bupivacaine HCl): Recall - Presence of Glass Particulate Matter
[Posted 05/09/2016] Fresenius Kabi indicated in its recall notice that the presence of glass particulate matter in solution, if undetected and administered via the epidural route, could block drug...
Ask a question
To post your own question to this support group, sign in or create an account.